Research ExplorerScientific StaffCarsten Bokemeyer Publications

Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations
Affiliations
751 - 794 out of 794Page size: 50

Publications

  1. 2007

  2. The translocations t(6;18;11)(q24;q21;q21) and t(11;14;18)(q21;q32;q21) lead to a fusion of the API2 and MALT1 genes and occur in MALT lymphomas.

    Murga-Penas, E-M., Eva, M., Callet-Bauchu, E., Ye, H., Albert, N., Albert, N., Copie-Bergman, C., Gazzo, S., Berger, F., Bokemeyer, C., Bokemeyer, C., Dierlamm, J. & Dierlamm, J., 2007, In: HAEMATOLOGICA. 92, 3, p. 405-409 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Tolerance to chemotherapy in elderly patients with cancer.

    Wedding, U., Honecker, F., Bokemeyer, C., Pientka, L. & Höffken, K., 2007, In: Cancer Control. 14, 1, p. 44-56 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.

    Heuser, M., Ganser, A. & Bokemeyer, C., 2007, In: SEMIN HEMATOL. 44, 3, p. 148-156 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2006

  6. Aprepitant as salvage therapy in patients with chemotherapy-induced nausea and emesis refractory to prophylaxis with 5-HT(3) antagonists and dexamethasone

    Oechsle, K., Müller, M. R., Hartmann, J. T., Kanz, L. & Bokemeyer, C., 12.2006, In: ONKOLOGIE. 29, 12, p. 557-61 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cells

    Atanackovic, D., Schnee, B., Schuch, G., Faltz, C., Schulze, J., Weber, C. S., Schafhausen, P., Bartels, K., Bokemeyer, C., Brunner-Weinzierl, M. C. & Deter, H-C., 07.2006, In: J NEUROIMMUNOL. 176, 1-2, p. 141-52 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)

    Kollmannsberger, C., Schittenhelm, M., Honecker, F., Tillner, J., Weber, D., Oechsle, K., Kanz, L. & Bokemeyer, C., 06.2006, In: ANN ONCOL. 17, 6, p. 1007-13 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma

    Hartmann, J. T., Oechsle, K., Huober, J., Jakob, A., Azemar, M., Horger, M., Kanz, L. & Bokemeyer, C., 05.2006, In: INVEST NEW DRUG. 24, 3, p. 249-53 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Germ cell lineage differentiation in non-seminomatous germ cell tumours

    Honecker, F., Stoop, H., Mayer, F., Bokemeyer, C., Castrillon, D. H., Lau, Y-F. C., Looijenga, L. H. J. & Oosterhuis, J. W., 02.2006, In: J PATHOL. 208, 3, p. 395-400 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 2005

  12. Anaemia in cancer patients: pathophysiology, incidence and treatment

    Bokemeyer, C., Oechsle, K. & Hartmann, J-T., 12.2005, In: EUR J CLIN INVEST. 35 Suppl 3, p. 26-31 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Guidelines on testicular cancer

    Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Horwich, A., Klepp, O., Laguna, M. P. & Pizzocaro, G., 12.2005, In: EUR UROL. 48, 6, p. 885-94 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels

    Horstmann, M., Merseburger, A. S., von der Heyde, E., Serth, J., Wegener, G., Mengel, M., Feil, G., Hennenlotter, J., Nagele, U., Anastasiadis, A., Bokemeyer, C., Stenzl, A. & Kuczyk, M., 11.2005, In: J CANCER RES CLIN. 131, 11, p. 715-22 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey

    Barrett-Lee, P., Bokemeyer, C., Gascón, P., Nortier, J. W. R., Schneider, M., Schrijvers, D., Van Belle, S. & ECAS Advisory Board and Participating Centers, 10.2005, In: ONCOLOGIST. 10, 9, p. 743-57 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Passive Immuntherapie mit monoklonalen Antikörpern

    Bokemeyer, C. & Panse, J., 10.2005, In: ONKOLOGIE. 28 Suppl 4, p. 9-13 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge

    Holweger, K., Bokemeyer, C. & Lipp, H-P., 09.2005, In: J CANCER RES CLIN. 131, 9, p. 559-67 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

    Köhne, C-H., van Cutsem, E., Wils, J., Bokemeyer, C., El-Serafi, M., Lutz, M. P., Lorenz, M., Reichardt, P., Rückle-Lanz, H., Frickhofen, N., Fuchs, R., Mergenthaler, H-G., Langenbuch, T., Vanhoefer, U., Rougier, P., Voigtmann, R., Müller, L., Genicot, B., Anak, O., Nordlinger, B. & European Organisation for Research and Treatment of Cancer Gastrointestinal Group, 01.08.2005, In: J CLIN ONCOL. 23, 22, p. 4856-65 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO

    Kollmannsberger, C., Budach, W., Stahl, M., Schleucher, N., Hehr, T., Wilke, H., Schleicher, J., Vanhoefer, U., Jehle, E. C., Oechsle, K., Trarbach, T., Boehlke, I., Kanz, L., Hartmann, J. T. & Bokemeyer, C., 08.2005, In: ANN ONCOL. 16, 8, p. 1326-33 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors

    Hartmann, J. T., Rick, O., Oechsle, K., Kuczyk, M., Gauler, T., Schöffski, P., Schleicher, J., Mayer, F., Teichmann, R., Kanz, L. & Bokemeyer, C., 08.2005, In: ANN SURG. 242, 2, p. 260-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study

    Stoop, H., Honecker, F., Cools, M., de Krijger, R., Bokemeyer, C. & Looijenga, L. H. J., 06.2005, In: HUM REPROD. 20, 6, p. 1466-76 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines

    Mayer, F., Mueller, S., Malenke, E., Kuczyk, M., Hartmann, J. T. & Bokemeyer, C., 06.2005, In: INVEST NEW DRUG. 23, 3, p. 205-11 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals

    Becherer, A., De Santis, M., Karanikas, G., Szabó, M., Bokemeyer, C., Dohmen, B. M., Pont, J., Dudczak, R., Dittrich, C. & Kletter, K., 05.2005, In: EUR J RADIOL. 54, 2, p. 284-8 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY

    Kersemaekers, A-M. F., Honecker, F., Stoop, H., Cools, M., Molier, M., Wolffenbuttel, K., Bokemeyer, C., Li, Y., Lau, Y-F. C., Oosterhuis, J. W. & Looijenga, L. H. J., 05.2005, In: HUM PATHOL. 36, 5, p. 512-21 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib

    Hartmann, U., Balabanov, S., Ziegler, P., Fellenberg, J., van der Kuip, H., Duyster, J., Lipp, H-P., Bokemeyer, C., Kanz, L. & Brümmendorf, T. H., 05.2005, In: EXP HEMATOL. 33, 5, p. 542-9 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer

    Wierecky, J., Kollmannsberger, C., Boehlke, I., Kuczyk, M., Schleicher, J., Schleucher, N., Metzner, B., Kanz, L., Hartmann, J. T. & Bokemeyer, C., 04.2005, In: J CANCER RES CLIN. 131, 4, p. 255-60 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Impact of tumor size on the long-term survival of patients with early stage renal cell cancer

    Kuczyk, M., Wegener, G., Merseburger, A. S., Anastasiadis, A., Machtens, S., Zumbrägel, A., Hartmann, J. T., Bokemeyer, C., Jonas, U. & Stenzl, A., 02.2005, In: WORLD J UROL. 23, 1, p. 50-4 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial

    Benoehr, P., Krueth, P., Bokemeyer, C., Grenz, A., Osswald, H. & Hartmann, J. T., 02.2005, In: J AM SOC NEPHROL. 16, 2, p. 452-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Kompressionssyndrome

    Wierecky, J. & Bokemeyer, C., 01.2005, In: INTERNIST. 46, 1, p. 9-18 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Cancer-related anemia: pathogenesis, prevalence and treatment

    Birgegård, G., Aapro, M. S., Bokemeyer, C., Dicato, M., Drings, P., Hornedo, J., Krzakowski, M., Ludwig, H., Pecorelli, S., Schmoll, H., Schneider, M., Schrijvers, D., Shasha, D. & Van Belle, S., 2005, In: ONCOLOGY-BASEL. 68 Suppl 1, p. 3-11 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?

    Birgegård, G. & Bokemeyer, C., 2005, In: ONCOLOGY-BASEL. 69 Suppl 2, p. 17-21 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Wirksamkeit und Toxizität der Taxane

    Lipp, H-P. & Bokemeyer, C., 2005, In: Pharmazie in unserer Zeit. 34, 2, p. 128-37 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. 2004

  34. Chemotherapie von Keimzelltumoren

    Beyer, J. & Bokemeyer, C., 12.2004, In: UROLOGE. 43, 12, p. 1507-13 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

    Hofheinz, R-D., Hartmann, J. T., Willer, A., Oechsle, K., Hartung, G., Gnad, U., Saussele, S., Kreil, S., Bokemeyer, C., Hehlmann, R. & Hochhaus, A., 31.08.2004, In: BRIT J CANCER. 91, 5, p. 834-8 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil

    Hartmann, J. T., Oechsle, K., Jäger, E., Reis, H. E., Haag, C., Niederle, N., Wilke, H-J., Pflüger, K-H., Batran, S. A., Büchele, T., Hofheinz, R. D., Kanz, L. & Bokemeyer, C., 06.2004, In: ANTI-CANCER DRUG. 15, 5, p. 473-7 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management

    Pfannenberg, A. C., Oechsle, K., Bokemeyer, C., Kollmannsberger, C., Dohmen, B. M., Bares, R., Hartmann, J. T., Vonthein, R. & Claussen, C. D., 06.2004, In: WORLD J UROL. 22, 2, p. 132-9 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial

    De Santis, M., Becherer, A., Bokemeyer, C., Stoiber, F., Oechsle, K., Sellner, F., Lang, A., Kletter, K., Dohmen, B. M., Dittrich, C. & Pont, J., 15.03.2004, In: J CLIN ONCOL. 22, 6, p. 1034-9 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. [ ¹⁸F]FDG-PET, CT/MRT und Tumormarker als prädiktive Indikatoren für das Ansprechen unter Hochdosis-Chemotherapie bei Patienten mit metastasierten Keimzelltumoren

    Pfannenberg, A. C., Oechsle, K., Kollmannsberger, C., Dohmen, B. M., Bokemeyer, C., Bares, R., Vontheim, R. & Claussen, C. D., 01.2004, In: ROFO-FORTSCHR RONTG. 176, 1, p. 76-84 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2003

  41. Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

    Hartmann, J. T., Oechsle, K., Quietzsch, D., Wein, A., Hofheinz, R. D., Honecker, F., Nehls, O., Köhne, C-H., Käfer, G., Kanz, L. & Bokemeyer, C., 01.12.2003, In: BRIT J CANCER. 89, 11, p. 2051-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

    Reichardt, P., Oechsle, K., Pink, D., Bokemeyer, C., Schneller, F., Issels, R., Kanz, L. & Hartmann, J. T., 11.2003, In: INVEST NEW DRUG. 21, 4, p. 481-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas

    Hartmann, J. T., Oechsle, K., Mayer, F., Kanz, L. & Bokemeyer, C., 25.06.2003, In: ANTICANCER RES. 23, 2C, p. 1899-901 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. 2002

  45. Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

    Bokemeyer, C., Oechsle, K., Hartmann, J. T., Schöffski, P., Schleucher, N., Metzner, B., Schleicher, J. & Kanz, L., 04.11.2002, In: BRIT J CANCER. 87, 10, p. 1066-71 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma

    Kollmannsberger, C., Oechsle, K., Dohmen, B. M., Pfannenberg, A., Bares, R., Claussen, C. D., Kanz, L. & Bokemeyer, C., 01.05.2002, In: CANCER-AM CANCER SOC. 94, 9, p. 2353-62 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET

    Bokemeyer, C., Kollmannsberger, C., Oechsle, K., Dohmen, B. M., Pfannenberg, A., Claussen, C. D., Bares, R. & Kanz, L., 12.02.2002, In: BRIT J CANCER. 86, 4, p. 506-11 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 2001

  49. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma

    De Santis, M., Bokemeyer, C., Becherer, A., Stoiber, F., Oechsle, K., Kletter, K., Dohmen, B. M., Dittrich, C. & Pont, J., 01.09.2001, In: J CLIN ONCOL. 19, 17, p. 3740-4 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. 1988

  51. Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines

    Verbeek, W., Bokemeyer, C., Falk, H. & Schmoll, H. J., 1988, In: J CANCER RES CLIN. 114, 6, p. 553-8 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. 1987

  53. Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells

    Gabius, H. J., Bokemeyer, C., Hellmann, T. & Schmoll, H. J., 1987, In: J CANCER RES CLIN. 113, 2, p. 126-30 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...12 13 14 15 16 Next